Brokerages expect II-VI, Inc. (NASDAQ:IIVI) to post $0.56 earnings per share for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for II-VI’s earnings. The highest EPS estimate is $0.57 and the lowest is $0.54. II-VI reported earnings per share of $0.32 in the same quarter last year, which suggests a positive year-over-year growth rate of 75%. The company is expected to issue its next quarterly earnings results on Tuesday, October 30th.

According to Zacks, analysts expect that II-VI will report full-year earnings of $2.49 per share for the current financial year, with EPS estimates ranging from $2.31 to $2.80. For the next fiscal year, analysts expect that the business will report earnings of $2.88 per share, with EPS estimates ranging from $2.43 to $3.07. Zacks’ EPS averages are an average based on a survey of research analysts that that provide coverage for II-VI.

II-VI (NASDAQ:IIVI) last released its earnings results on Tuesday, August 7th. The scientific and technical instruments company reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.13. II-VI had a return on equity of 10.09% and a net margin of 7.59%. The firm had revenue of $321.10 million during the quarter, compared to analysts’ expectations of $301.45 million. During the same period in the prior year, the company earned $0.50 earnings per share. The company’s quarterly revenue was up 17.3% on a year-over-year basis.

Several equities research analysts have weighed in on IIVI shares. BidaskClub upgraded II-VI from a “sell” rating to a “hold” rating in a research note on Friday, June 8th. Morgan Stanley cut II-VI from an “overweight” rating to an “equal weight” rating and set a $46.00 target price for the company. in a research note on Monday, July 2nd. They noted that the move was a valuation call. Zacks Investment Research upgraded II-VI from a “sell” rating to a “hold” rating and set a $47.00 target price for the company in a research note on Wednesday, July 4th. Cowen started coverage on II-VI in a research note on Monday, July 23rd. They set an “outperform” rating and a $57.00 target price for the company. Finally, ValuEngine cut II-VI from a “buy” rating to a “hold” rating in a research note on Tuesday, July 31st. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $53.69.

In related news, CEO Vincent D. Mattera, Jr. sold 9,450 shares of the firm’s stock in a transaction on Wednesday, August 1st. The stock was sold at an average price of $39.79, for a total transaction of $376,015.50. Following the completion of the transaction, the chief executive officer now directly owns 250,310 shares of the company’s stock, valued at approximately $9,959,834.90. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP David G. Wagner sold 33,076 shares of the firm’s stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $48.01, for a total value of $1,587,978.76. Following the transaction, the vice president now directly owns 71,578 shares of the company’s stock, valued at $3,436,459.78. The disclosure for this sale can be found here. Insiders sold a total of 92,241 shares of company stock valued at $4,203,019 over the last quarter. 3.80% of the stock is owned by corporate insiders.

Large investors have recently made changes to their positions in the stock. Russell Investments Group Ltd. raised its position in II-VI by 6.6% during the 1st quarter. Russell Investments Group Ltd. now owns 19,129 shares of the scientific and technical instruments company’s stock worth $782,000 after purchasing an additional 1,185 shares during the last quarter. Ontario Teachers Pension Plan Board bought a new position in II-VI during the 2nd quarter worth $384,000. Schwab Charles Investment Management Inc. raised its position in II-VI by 6.1% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 380,920 shares of the scientific and technical instruments company’s stock worth $16,551,000 after purchasing an additional 22,007 shares during the last quarter. Private Advisor Group LLC bought a new position in II-VI during the 2nd quarter worth $455,000. Finally, BlackRock Inc. raised its position in II-VI by 9.3% during the 2nd quarter. BlackRock Inc. now owns 8,651,418 shares of the scientific and technical instruments company’s stock worth $375,905,000 after purchasing an additional 739,662 shares during the last quarter. 92.95% of the stock is owned by institutional investors and hedge funds.

NASDAQ IIVI opened at $48.35 on Tuesday. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.22 and a quick ratio of 2.17. II-VI has a fifty-two week low of $36.60 and a fifty-two week high of $53.08. The firm has a market cap of $3.06 billion, a price-to-earnings ratio of 28.11, a price-to-earnings-growth ratio of 1.46 and a beta of 0.19.

About II-VI

II-VI Incorporated develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide. The company operates in three segments: II-VI Laser Solutions, II-VI Photonics, and II-VI Performance Products. The II-VI Laser Solutions segment offers optical and electro-optical components and materials primarily used in high-power CO2 lasers; fiber-delivered beam delivery systems, and processing tools and direct diode lasers for industrial lasers; direct diode laser modules, sub-systems, and systems; super-hard materials processing laser systems; and compound semiconductor epitaxial and gallium arsenide wafers.

Recommended Story: Book Value Of Equity Per Share – BVPS Explained

Get a free copy of the Zacks research report on II-VI (IIVI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for II-VI (NASDAQ:IIVI)

Receive News & Ratings for II-VI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for II-VI and related companies with MarketBeat.com's FREE daily email newsletter.